Investing around $100 million per year in India, says Claudio Facchin of ABB-February 2024-www.financetom.com

Investing around $100 million per year in India, says Claudio Facchin of ABB

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Investing around $100 million per year in India, says Claudio Facchin of ABB

May 2, 2018 11:03 AM

Claudio Facchin, president of power grids division, ABB, said that company is investing approximately $100 million per year in India.

He added that investments in India will go towards developing and supporting innovation, technology advancement.

First Published:May 2, 2018 8:03 PM IST

Previous page： Textron's Aviation Unit to Sell Three Beechcraft King Air 360C Aircraft to Gama Aviation Next page： Eni's 'Satellite' Strategy Boosts Valuation, Accelerates Debt Reduction, RBC Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Textron's Aviation Unit to Sell Three Beechcraft King Air 360C Aircraft to Gama Aviation

Jul 29, 2024

11:01 AM EDT, 07/29/2024 (MT Newswires) -- Textron's ( TXT ) Textron Aviation unit said Monday it has signed an agreement with Gama Aviation to sell Gama three cargo door-equipped Beechcraft King Air 360C aircraft. Financial terms of the agreement weren't disclosed. Textron Aviation said it intends to deliver the aircraft next year. The aircraft is intended to help support...

Eni's 'Satellite' Strategy Boosts Valuation, Accelerates Debt Reduction, RBC Says

Jul 29, 2024

11:01 AM EDT, 07/29/2024 (MT Newswires) -- Eni (E) is showing progress in its satellite strategy for the energy transition by selling parts of its companies Plenitude and Enilive at much higher prices than their current value, which will help its debt and make its distribution plans more defensive compared to its competitors, RBC Capital Markets said in a note...

Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further

Jul 29, 2024

Ventyx Biosciences Inc ( VTYX ) stock is trading lower on Monday. The company released results from the Phase 2 trial of allosteric TYK2 inhibitor VTX958 in participants with moderately to severely active Crohn’s disease, a type of inflammatory bowel disease that irritates and causes swelling in digestive tract. The Phase 2 trial enrolled 109 participants randomized to one of two...

Snowflake Unusual Options Activity For July 29

Jul 29, 2024

Whales with a lot of money to spend have taken a noticeably bullish stance on Snowflake. Looking at options history for Snowflake we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 40% with bearish. From the overall spotted trades, 7 are...